 | Aquestive Therapeutics, Inc. | |||
| NGM : AQST || Location: United States | ||||
$4.07+0.14 (+3.56%) |
1.95 M | 3.97 - 4.25 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 4.009 M |
| March 28, 2024 | 2.273 M |
| March 15, 2024 | 2.316 M |
| Feb. 29, 2024 | 1.812 M |
| Feb. 15, 2024 | 1.989 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.08 | -0.11 | -34.80% |
| 09/30/2023 | -0.12 | -0.03 | 74.03% |
| 06/30/2023 | -0.12 | -0.10 | 16.94% |
| 03/31/2023 | -0.19 | -0.12 | 37.76% |
| 12/31/2022 | -0.24 | -0.23 | 2.29% |
AQST Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 89.968M | Shares Float | 65.069M |
| Short Float | 4.009M | Market Cap | 353.57M |
| Institution ownership | 34.16% | Insider ownership | 4.998% |
| Earnings Date | 04/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.13 | Forward EPS | -0.30 |